A pulmonary vascular resistance of 8 Woods units per meter squared defines operablity in congenital heart disease

Similar documents
Clinical History. CHD-PAH Case: Physical Exam. Clinical History. To Repair or not to Repair?

Predictors of unfavorable outcome after atrial septal defect closure in adults

Pulmonary Hypertension: Follow-up in adolescence and adults

COMPLEX CONGENITAL HEART DISEASE: WHEN IS IT TOO LATE TO INTERVENE?

Clinicians and Facilities: RESOURCES WHEN CARING FOR WOMEN WITH ADULT CONGENITAL HEART DISEASE OR OTHER FORMS OF CARDIOVASCULAR DISEASE!!

Pulmonary Hypertension Associated with Congenital Heart Disease. Amiram Nir Hadassah, Jerusalem

Latest Results from Clinical Trials (MAESTRO)

Echocardiographic assessment in Adult Patients with Congenital Heart Diseases

Eisenmenger Syndrome: A Call for Action

Management of complex CHD in adults

ECHOCARDIOGRAPHIC APPROACH TO CONGENITAL HEART DISEASE: THE UNOPERATED ADULT

ADULT CONGENITAL HEART DISEASE. Stuart Lilley

Pediatric PAH after successful neonatal arterial switch operation for transposition of the great arteries

5.8 Congenital Heart Disease

How pregnancy impacts adult cyanotic congenital heart disease

Index. cardiology.theclinics.com. Note: Page numbers of article titles are in boldface type.

Survival and Predictors of Death in Eisenmenger Syndrome

CONGENITAL HEART DISEASE (CHD)

ADULT CONGENITAL HEART DISEASE AN UPDATE FOR CARDIOLOGISTS AND PRIMARY CARE PHYSICIANS

Surgical Management of TOF in Adults. Dr Flora Tsang Associate Consultant Department of Cardiothoracic Surgery Queen Mary Hospital

Common Defects With Expected Adult Survival:

Adult Congenital Heart Disease T S U N ` A M I!

The role of intraoperative TOE in congenital cardiac surgery

Cardiac MRI in ACHD What We. ACHD Patients

Cardiac Emergencies in Infants. Michael Luceri, DO

4/21/2018. The Role of Cardiac Catheterization in Pediatric PVD. The Role(s) of Cath in PVD. Pre Cath Management. Catheterization Mechanics in PVD

Congenital Heart Disease

The Dilated Pulmonary Artery: Is there a risk of Dissection?

Echocardiography in Adult Congenital Heart Disease

Changing demographics of pulmonary arterial hypertension in congenital heart disease

Research Presentation June 23, Nimish Muni Resident Internal Medicine

Mitral Valve Disease, When to Intervene

Stepwise Approach Using Combined Management in Patients with Congenital Heart Disease and Borderline Pulmonary Vascular Disease

Cases in Adult Congenital Heart Disease

RVOTO adult and post-op

Right Heart Catheterization. Franz R. Eberli MD Chief of Cardiology Stadtspital Triemli, Zurich

Candice Silversides, MD Toronto Congenital Cardiac Centre for Adults University of Toronto Toronto, Canada

Congenital heart disease. By Dr Saima Ali Professor of pediatrics

Changing Profile of Adult Congenital Heart Disease

Outline. Congenital Heart Disease. Special Considerations for Special Populations: Congenital Heart Disease

When to implant an ICD in systemic right ventricle?

ΔΙΑΧΕΙΡΙΣΗ ΑΣΘΕΝΩΝ ΜΕ ΜΕΣΟΚΟΛΠΙΚΗ ΕΠΙΚΟΙΝΩΝΙΑ ΖΑΧΑΡΑΚΗ ΑΓΓΕΛΙΚΗ ΚΑΡΔΙΟΛΟΓΟΣ ΗΡΑΚΛΕΙΟ - ΚΡΗΤΗ

Anatomy & Physiology

Closing ASDs with pulmonary hypertension. Shakeel A Qureshi Evelina Children s Hospital London

Tennessee Chapter of ACC Adult Congenital Heart Disease: Complex Thoughts on Simple Lesions & Simple Thoughts on Complex Lesions

A New Radiopaque Surgical Suture* Juro WADA, M.D. and Masahiro ENDO, M.D.

Congenital heart disease: When to act and what to do?

2010 년순환기관련학회춘계통합학술대회. Kim, Soo-Jin. Sejong General Hospital, Sejong Cardiovascular center

Congenital Heart Disease An Approach for Simple and Complex Anomalies

M/3, cc-tga, PS, BCPC(+) Double Switch Operation

Surgical Treatment for Atrioventricular Septal Defect. Masakazu Nakao Consultant, Paediatric Cardiothoracic Surgery

Adult Congenital Heart Disease for the Internist

Adult Congenital Heart Disease for the Internist

ACHD & Heart Disease and Pregnancy: Guidelines and Cases Michael A. Gatzoulis

Uptofate Study Summary

Tricuspid valve surgery in patients with a systemic right ventricle

DECLARATION OF CONFLICT OF INTEREST

Risk Stratification in ACHD

Comparison between adult and pediatric populations with I/HPAH and PAH-CHD in the Bologna ARCA registry

9/8/2009 < 1 1,2 3,4 5,6 7,8 9,10 11,12 13,14 15,16 17,18 > 18. Tetralogy of Fallot. Complex Congenital Heart Disease.

Low-dose prospective ECG-triggering dual-source CT angiography in infants and children with complex congenital heart disease: first experience

Down Syndrome Medical Interest Group Friday, 12 June Cardiac Surgery in patients with Down Syndrome

How does Pulmonary Hypertension Affect the Decision to Intervene in Mitral Valve Disease? NO DISCLOSURE

Adults with Congenital Heart Disease. Michael E. McConnell MD, Wendy Book MD Teresa Lyle RN NNP

Late Results after Correction of Ventricular Septal Defect with Severe Pulmonary Hypertension

Adult Congenital Heart Disease

Stenosis of Pulmonary Veins

CMR for Congenital Heart Disease

Congenital Heart Defects

CONGENITAL HEART LESIONS ((C.H.L

Adult Congenital Heart Disease: What All Echocardiographers Should Know Sharon L. Roble, MD, FACC Echo Hawaii 2016

Pregnancy, Heart Disease and Imaging. Hemodynamics. Decreased systemic vascular resistance. Physiology anemia

CYANOTIC CONGENITAL HEART DISEASES. PRESENTER: DR. Myra M. Koech Pediatric cardiologist MTRH/MU

Deok Young Choi, Gil Hospital, Gachon University NEONATES WITH EBSTEIN S ANOMALY: PROBLEMS AND SOLUTION

Cardiopulmonary exercise test among children with congenital heart diseases: a multicenter study

Mædica - a Journal of Clinical Medicine

Interventional MRI (i-mri)

2018 Guideline for the Management of Adults with Congenital Heart Disease

By Dickens ATURWANAHO & ORIBA DAN LANGOYA MAKchs, MBchB CONGENTAL HEART DISEASE

Adult Echocardiography Examination Content Outline

Evaluation of the Right Ventricle and Risk Stratification for Sudden Cardiac Death

Children with Single Ventricle Physiology: The Possibilities

PULMONARY ARTERY HYPERTENSION (PAH) leading

Management of Heart Failure in Adult with Congenital Heart Disease

Complex Congenital Heart Disease in Adults

1682 MASAKI N et al. Circ J 2018; 82: ORIGINAL ARTICLE doi: /circj.CJ

Adult Congenital Heart Disease: What Every Practitioner Should Know

Assessing the Impact on the Right Ventricle

Adults with Congenital Heart Disease

Published online 2014 November 26. Research Article

3/14/2011 MANAGEMENT OF NEWBORNS CARDIAC INTENSIVE CARE CONFERENCE FOR HEALTH PROFESSIONALS IRVINE, CA. MARCH 7, 2011 WITH HEART DEFECTS

Adult Congenital Heart Disease: The New Reality. Disclosures

Management of a Patient after the Bidirectional Glenn

Ventricular Interactions in the Normal and Failing Heart

Absent Pulmonary Valve Syndrome

THE SPECTRUM OF PAEDIATRIC CARDIAC DISEASE IN VANUATU. Dr Annette Garae (PGDCH)

The Chest X-ray for Cardiologists

The right ventricle in chronic heart failure

pulmonary thrombosis in Eisenmenger ASD: A case report

The Double Switch Using Bidirectional Glenn and Hemi-Mustard. Frank Hanley

Transcription:

A pulmonary vascular resistance of 8 Woods units per meter squared defines operablity in congenital heart disease RMF Berger Beatrix Children s Hospital University Medical Center Groningen The Netherlands

A pulmonary vascular resistance of 8 Woods units per meter squared defines operablity in congenital heart disease RMF Berger Beatrix Children s Hospital University Medical Center Groningen The Netherlands

8 WUm2

A pulmonary vascular resistance of 8 Woods units per meter squared defines operablity in congenital heart disease To be considered. Clinical characteristics Age PVR (PVR/SVR ratio) Qp:Qs Cardiac morphology Associated anomalies

Pulmonary Arterial Hypertension PAH in CHD assessment of reversibility reversible? irreversible Clinical characteristics Hemodynamics and pulmonary vasoreactivity Lung biopsy Pulmonary arterial wedge angiography Pre-treatment? Berger, Eur Heart J 2000

Perioperative risks Survival in Eisenmenger syndrome vs corrected VSD corrected VSD 2 Eisenmenger, simple 1 Eisenmenger, complex 1 1. Daliento L et al. Eur Heart J 1998 2. Roos-Hesselink J et al. Eur Heart J 2004

Survival in Eisenmenger syndrome Based on type of heart defect, age Diller G-P et al. Eur Heart J 2006 Van Loon et al. Am Heart J 2007 Eisenmenger s s syndrome: marked restriction in exercise capacity Aortic coarction Tetralogy of Fallot VSD Mustard-operation Valvular disease Ebsteins anomaly Pulmonary atresia Fontan-operation ASD (late closure) cctga Complex anatomy Eisenmenger s ANOVA p<0.0001 Mean ± SD 28.7 ± 10.4 25.5 ± 9.1 23.4 ± 8.9 23.3 ± 7.4 22.7 ± 7.6 20.8 ± 4.2 20.1 ± 6.5 19.8 ± 5.8 19.2 ± 6.2 18.6 ± 6.9 14.6 ± 4.7 11.5 ± 3.6 5 10 15 20 25 30 35 Peak VO 2 (ml/kg/min) 40 Diller GP, et al. Circulation 2005; 112: 828 835.

Correlation between pre-op biopsy findings and pulmonary arterial pressure after operation Rabinovitch et al, Circulation 1984 PULMONARY VASCULAR RESISTANCE DURING EXERCISE LATE AFTER REPAIR OF LARGE VENTRICULAR SEPTAL DEFECTS Follow up 9-21 yrs (mean 14.5 yrs) Ikawa et al, J Thorac Cardiovasc Surg 1995

Regression of Pulmonary Vascular Disease At young age (< 9 mo 1 yr) Rabinovitch et al, Circulation 1984 After PA-banding Wagenvoort et al, J Thorac Cardiovasc Surg 1984 Batista et al, Arq Bras Cardiol. 1997 After hemodynamic unloading (experimental) Rabinovitch J Thorac Cardiovasc Surg. 2001 Antiproliferative drugs Long-term outcome of patients operated for large ventricular septal defects with increased pulmonary vascular resistance Kannan BR et al, Indian Heart J 2003 Cohort of patients with non-restrictive VSD and PVR > 6 WU.m2 38 patients, age 6 months 27 years (median 7.5 yrs) Operated between 1985-1996 Pre-op hemodynamic variables: PVR 7.6 ± 1.8 Wood s units Qp : Qs 1.9 ± 0.48 PVR/SVR 0.41 ± 0.12 Mean follow-up 8.7 yrs 30 patients (80%) had a good outcome: asymptomatic, significant reduction in PAP 8 patients (20%) poor outcome: 5 immediate post-op deaths, 1 late death 2 surviving with persistent severe PH

Long-term outcome of patients operated for large ventricular septal defects with increased pulmonary vascular resistance n=11 PVR (WU.m2) PVR/SVR mean 8.7 yrs Kannan BR et al, Indian Heart J. 2003 ASD with pulmonary vascular disease Prediction of outcome after surgical correction 702 patients 40 (6%) pulm vasc disease TPR > 7 WU.m2 26 surgical closure 14 medical treatment Median follow up 12 yrs Steele et al.,circulation 1987

ASD with pulmonary vascular disease Prediction of outcome after surgical correction Surgical treatment Medical treatment Steele et al.,circulation 1987 Rp during preoperative testing according to outcome following surgery Balzer, et al. Circulation 2002

8 WU.m2

Would you deny surgical repair to a patient with a pulmonary vascular resistance of 8 Woods units per meter squared?

All old data..?? Anzheng Hospital Bejing, China; Gan H-L et al 1212 patients with cong. syst-to-pulm shunt and advanced pulmonary hypertension (1990-2008) the patients were entered into 2 groups respectively: non-surgical group (n=297 cases) and surgical group (n= 915). the age when the closure procedure was undertaken ranged from 13 months to 37 yrs old. The mean follow-up period was 97.2±57.36 months propensity scores were estimated using unconditional logistic regression to determine the predicted probability of inclusion into the surgical group for each of the 1212 patients. Gan et al, WCPCCS, Cairns 2009

Definition of a prospensity score Clinical features Age / Sex Clinical right heart failure Hemoptysis Cyanosis at rest / on exertion Clubbing fingers and toes Systolic heart murmur II/VI Hemoglobin Shunt level NYHA functional class III 6MWD Echocardiography LVEF Bidirectional shunt on TTE Severe tricuspid regurgitation Hemodynamics Right atrium pressure PVR QP/QS SPAP SPAP/SBP mpap SaO2 / PaO2 Positive reaction to NO / O2 Gan et al, WCPCCS, Cairns 2009 Gan et al, WCPCCS, Cairns 2009

PVRi < 8 WU.m2 A pulmonary vascular resistance of 8 Woods units per meter squared defines operablity in congenital heart disease, unless